Chemical activators of platelet-activating factor acetylhydrolase, isoform 1b, subunit 2, can modulate the enzyme's function through various mechanisms. Phosphatidylcholine and Lecithin, both containing choline and fatty acids, can be hydrolyzed to produce substrates, such as Lyso-PAF and free choline, that directly bind to the enzyme. This binding enhances the enzyme's acetylhydrolase activity by increasing substrate availability. Additionally, Ginkgolide B engages with the enzyme to promote its active conformation, thereby augmenting its activity. Arachidonic Acid, released from cell membranes, can be metabolized into various bioactive lipids that activate the enzyme by inducing conformational shifts that amplify its catalytic function. Similarly, Platelet-Activating Factor (PAF) itself acts as a substrate for the enzyme, directly triggering its hydrolytic activity upon binding.
In parallel, other molecules can influence intracellular signaling pathways to activate platelet-activating factor acetylhydrolase, isoform 1b, subunit 2. Forskolin and Dibutyryl cAMP, by elevating cAMP levels, activate protein kinase A (PKA), which can then phosphorylate the enzyme, leading to its activation. The same effect can be achieved with 3-Isobutyl-1-methylxanthine (IBMX), which raises cAMP levels by inhibiting phosphodiesterases. Sphingosine-1-phosphate, although not directly interacting with the enzyme, can affect the balance of cellular lipids that regulate the enzyme's activity, thus having an indirect activating effect. The increase in intracellular calcium levels by Calcium Ionophore A23187 can also promote the activation of the enzyme through conformational changes. In cases where specific inhibitors for LPCAT1 are employed, the resulting accumulation of lyso-PAF can activate the enzyme due to increased substrate presence. Each of these activators, whether by direct interaction with the enzyme or modulation of cellular pathways, can lead to an increase in the activity of platelet-activating factor acetylhydrolase, isoform 1b, subunit 2.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ginkgolide B | 15291-77-7 | sc-201037B sc-201037 sc-201037C sc-201037A | 5 mg 10 mg 25 mg 50 mg | $46.00 $64.00 $114.00 $201.00 | 8 | |
Ginkgolide B, a terpenoid from Ginkgo biloba, has been shown to enhance the activity of platelet-activating factor acetylhydrolase, isoform 1b, subunit 2 by binding to the enzyme and promoting its active conformation. | ||||||
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $92.00 $240.00 $4328.00 | 9 | |
Arachidonic Acid, upon being released from cell membranes, can be converted into bioactive lipids that can activate platelet-activating factor acetylhydrolase, isoform 1b, subunit 2 by inducing conformational changes that enhance its catalytic activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate can activate platelet-activating factor acetylhydrolase, isoform 1b, subunit 2 by influencing sphingolipid metabolism and the balance of cellular lipids that modulate the enzyme's activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium Ionophore A23187 can increase intracellular calcium levels, which can activate platelet-activating factor acetylhydrolase, isoform 1b, subunit 2 by promoting enzyme activity through conformational activation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl cAMP, a cell-permeable cAMP analog, can activate PKA, which in turn can phosphorylate and activate platelet-activating factor acetylhydrolase, isoform 1b, subunit 2. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX increases intracellular cAMP by inhibiting phosphodiesterases, which can lead to activation of PKA and subsequent activation of platelet-activating factor acetylhydrolase, isoform 1b, subunit 2. | ||||||